# FDA 483 - Diana P Castro, MD - November 26, 2025

Source: https://www.keypedia.com/records/483/diana-p-castro-md/421e1384-3712-450a-8e8f-8866790626ed

> FDA 483 for Diana P Castro, MD on November 26, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Diana P Castro, MD
- Inspection Date: 2025-11-26
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Diana P Castro, MD, a clinical investigator in Flower Mound, TX, revealed significant deficiencies in the conduct of a clinical investigation. The firm failed to ensure subjects met eligibility criteria and did not adhere to protocol-required assessments and timelines. Additionally, the inspection found multiple instances of incomplete, inaccurate, and non-contemporaneous documentation in case histories, raising concerns about data integrity and overall study oversight.

## Related Officers

- [Terri E. Gibson](https://www.keypedia.com/people/terri-e-gibson/f1a80f95-a5c4-4cae-9a4b-e23f367770bb)

Company: https://www.keypedia.com/companies/diana-p-castro-md/09a4eb67-6887-488c-8c17-0aa6409671d6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9